Source: ISSN: 1773-2247 ; Journal of Drug Delivery Science and Technology ; https://hal.science/hal-03078844 ; Journal of Drug Delivery Science and Technology, 2018, 43, pp.149 - 153.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD.

Authors : Ferreira, João Pedro; Vasques-Nóvoa, Francisco; Ferrão, Diana ...

Subjects: [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

Source: ISSN: 0149-5992.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Dissertation/ Thesis

Polymeric dosage forms with improved release kinetics for ketoprofen and fenofibrate ; Formes galéniques polymériques avec cinétiques de libération améliorée pour le kétoprofène et le fénofibrate

Authors : Gué, Emilie;

Subjects: Hot melt extrusion; Spray drying; Dispersions solides

Source: https://theses.hal.science/tel-01016003 ; Médecine humaine et pathologie. Université du Droit et de la Santé - Lille II, 2013. Français. ⟨NNT : 2013LIL2S026⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH.

Authors : Baron, Morgane; Leroyer, Aurélie, S.; Majd, Zouher ...

Subjects: microparticles; atherosclerosis; fatty liver disease

Source: ISSN: 0021-9150.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context

Authors : Monteillet, Laure; Gjorgjieva, Monika; Silva, Marine ...

Subjects: [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]

Source: ISSN: 2212-8778 ; Molecular metabolism ; https://inserm.hal.science/inserm-02339561 ; Molecular metabolism, 2018, 16, pp.100-115. ⟨10.1016/j.molmet.2018.07.006⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol

Authors : Winnicki, Camille; Leblond, Pierre; Bourdeaut, Franck ...

Subjects: pediatric oncology; brain tumors; metronomic chemotherapy

Source: ISSN: 2077-0383 ; Journal of Clinical Medicine ; https://hal.science/hal-04593818 ; Journal of Clinical Medicine, 2023, 12 (4), pp.1415. ⟨10.3390/jcm12041415⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.

Authors : Colin, Sophie; Briand, Olivier; Touche, Véronique ...

Subjects: PPARα; intestine; HDL

Source: ISSN: 0195-668X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.

Authors : Lalloyer, Fanny; Wouters, Kristiaan; Baron, Morgane ...

Subjects: PPARalpha; fatty liver disease; atherosclerosis

Source: ISSN: 1079-5642.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.

Authors : Delayre-Orthez, Carine; Becker, Julien; Guenon, Isabelle ...

Subjects: MESH: Animals; MESH: Chemotactic Factors; MESH: PPAR alpha

Source: ISSN: 1465-9921 ; Respiratory Research ; https://inserm.hal.science/inserm-00090225 ; Respiratory Research, 2005, 6, pp.91. ⟨10.1186/1465-9921-6-91⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.

Authors : Tabernero, Antonia; Schoonjans, Kristina; Jesel, Laurence ...

Subjects: MESH: Animals; MESH: Antilipemic Agents; MESH: Procetofen

Source: ISSN: 1471-2210 ; BMC Pharmacology ; https://inserm.hal.science/inserm-00124786 ; BMC Pharmacology, 2002, 2, pp.10.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Use of mouse model in pharmacokinetic studies of poorly water soluble drugs: Application to fenofibrate

Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD.

Polymeric dosage forms with improved release kinetics for ketoprofen and fenofibrate ; Formes galéniques polymériques avec cinétiques de libération améliorée pour le kétoprofène et le fénofibrate

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH.

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol

Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.

Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.

PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.

اتصل بنا

اتبع